首页>
外国专利>
A process for the preparation of new benzoselemino (4,3,2-cd) indazoles.
A process for the preparation of new benzoselemino (4,3,2-cd) indazoles.
展开▼
机译:一种制备新的苯并硒基(4,3,2-cd)吲唑的方法。
展开▼
页面导航
摘要
著录项
相似文献
摘要
A benzoselenino[4, 3, 2-cd] indazole compound having in free base form the following general formula CHEM amd the pharmaceutically acceptable salts thereof, wherein: R7, R8, R9 and R10 independently represent hydrogen, hydroxy or alkoxy of from one to four carbon atoms; R2 is ANR min R sec in which A is a straight or branched alkylene chain of from two to five carbon atoms, optionally substituted with hydroxyl and in which R min and R sec are independently a hydrogen, a straight or branched alkyl of from one to four carbon atoms, optionally substituted with hydroxyl or R min and R sec when taken together, represent the bifunctional radical CHEM in which n and m are each, independently, the integer 2 or 3 and B is a direct bond or O, S or NR''' wherein R''' is hydrogen or straight or branched alkyl of from one to four carbon atoms, optionally substituted with hydroxyl; and R5 is nitro, NH2, NHR2 or NHR''' min wherein R''' min is a one to four carbon atom acyl radical, a chloroacetyl radical, -@-Z-NRxRy wherein Z is a straight or branched alkylene chain of from one to four carbon atoms and wherein Rx and Ry are each hydrogen, or a straight or branched alkyl of from one to four carbon atoms optionally substituted with hydroxy, R''' min is the group CHEM Also disclosed are methods for their production and pharmaceutical compositions comprising the compounds. Compounds of the invention have pharmacological properties and are useful antibacterial agents, antifungal agents, and antitumor agents.
展开▼
机译:具有游离碱形式的以下通式及其药学上可接受的盐的苯并硒吩并[4,3,2-cd]吲唑化合物及其药学上可接受的盐,其中:R 7,R 8,R 9和R 10各自独立地表示氢,羟基或烷氧基。 1-4个碳原子; R 2是ANR min R sec,其中A是二至五个碳原子的直链或支链亚烷基链,任选被羟基取代,并且其中R min和R sec独立地是氢,是一个从一个至另一个的直链或支链烷基。任选被羟基或R min和R sec取代的四个碳原子表示双官能基,其中n和m分别独立地为整数2或3,B为直接键或O,S或NR′′,其中R′′为氢或1-4个碳原子的直链或支链烷基,任选被羟基取代;或R 5是硝基,NH 2,NHR 2或NHR'min,其中R'min是1-4个碳原子的酰基,氯乙酰基,-@-Z-NR x R y,其中Z是直链或支链亚烷基1-4个碳原子,其中Rx和Ry分别为氢,或1-4个碳原子任选被羟基取代的直链或支链烷基,R'min为基团化合物的药物制备和药物组合物。本发明的化合物具有药理学性质,并且是有用的抗菌剂,抗真菌剂和抗肿瘤剂。
展开▼